Saad Shakir celebrates 25 years as DSRU Director

5 July 2024

In this month’s PharmaTimes, Saad Shakir gives an interview in which he reflects on his 25 years at the Drug Safety Research Unit. He focuses on the transition from reactive to proactive pharmacovigilance activities and the increased recognition of the value of real world data. This recognition has ensured that the DSRU’s expertise in designing and conducting real world safety studies is in great demand.

Read the full article here: http://magazine.pharmatimes.com/#/reader/51829/259337